Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (2): 360-368.doi: 10.13481/j.1671-587X.20210215
• Research in basic medicine • Previous Articles Next Articles
Guo HUANG1,Youquan WANG1(
),Juan CHEN2
Received:2020-08-15
Online:2021-03-28
Published:2021-03-25
Contact:
Youquan WANG
E-mail:gfzq1410@163.com
CLC Number:
Guo HUANG,Youquan WANG,Juan CHEN. Reverse effect of miR-138-5p targeted inhibition of HIF-1α expression on cisplatin resistance of breast cancer MCF-7 cells and its mechanism[J].Journal of Jilin University(Medicine Edition), 2021, 47(2): 360-368.
| 1 | BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. |
| 2 | PLEVRITIS S K, MUNOZ D, KURIAN A W, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012[J]. JAMA, 2018, 319(2):154-164. |
| 3 | 顾 峰, 周 岩, 韦培培. 乳腺癌患者外周血miRNA-134表达及化疗耐药的机制[J]. 重庆医学, 2018, 47(6):779-782. |
| 4 | 高 洁, 李晨曦, 赵 辉, 等. miR-19a-3p通过靶向PIK3CB参与调控雌激素受体阳性乳腺癌化疗耐药的相关研究[J]. 生物技术通讯, 2018, 29(5):587-592. |
| 5 | ZHAO C, LING X, LI X, et al. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1[J]. Breast Cancer, 2019, 26(6):817-825. |
| 6 | GAO Y, FAN X, LI W, et al. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124[J]. Biochem Biophys Res Commun, 2014, 446(1):179-186. |
| 7 | 闫东科, 吕 平. 低氧诱导因子及其抑制剂研究进展[J]. 生物技术进展, 2019, 9(4):332-340. |
| 8 | XU K, ZHAN Y, YUAN Z, et al. Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop [J]. Mol Ther, 2019, 27(10):1810-1824. |
| 9 | TRÉDAN O, GALMARINI C M, PATEL K, et al. Drug resistance and the solid tumor microenvironment[J]. J Natl Cancer Inst, 2007, 99(19):1441-1454. |
| 10 | 卢明华, 陶功财, 方亚男, 等. 缺氧导致胃癌化疗耐药的研究进展[J]. 中国肿瘤临床, 2019, 46(13):700-703. |
| 11 | MÉNDEZ-BLANCO C , FONDEVILA F, GARCÍA-PALOMO A, et al. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors[J]. Exp Mol Med, 2018, 50(10):1-9. |
| 12 | HAYES J, PERUZZI P P, LAWLER S. MicroRNAs in cancer: biomarkers, functions and therapy[J]. Trends Mol Med, 2014, 20(8):460-469. |
| 13 | SHIN V Y, Chu K M. MiRNA as potential biomarkers and therapeutic targets for gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10432-10439. |
| 14 | 余灵芝, 戴丹平, 项秀瑶. miR-20b通过抑制JAK/STAT3信号通路逆转结肠癌细胞5-FU耐药性的研究[J]. 世界华人消化杂志, 2019, 27(9):544-550. |
| 15 | 何 平, 王 平, 熊隆信. miR-429通过下调PTEN并激活PI3K/AKT信号通路促进胰腺癌PANC-1细胞对卡培他滨耐药[J]. 中国肿瘤生物治疗杂志, 2018, 25(12):1251-1258. |
| 16 | XIAO F, LI Y, WAN Y, et al. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B[J]. Cancer Chemother Pharmacol, 2018, 81(5):935-947. |
| 17 | NING J, JIAO Y, XIE X, et al. miR-138-5p modulates the expression of excision repair cross-complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin[J]. Oncol Rep, 2019, 41(2):1131-1139. |
| 18 | PAN X, CHEN Y, SHEN Y, et al. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7[J]. Cell Death Dis, 2019, 10(6): 429. |
| 19 | LIANG Z, FENG Q, XU L, et al. CREPT regulated by miR-138 promotes breast cancer progression[J]. Biochem Biophys Res Commun, 2017, 493(1):263-269. |
| 20 | LIU D, ZHANG Q, WANG J, et al. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer[J]. Pharmazie, 2019, 74(2):83-90. |
| 21 | WANG K, ZHU X, ZHANG K, et al. Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α[J]. J Biochem Mol Toxicol, 2018, 32(3):e22039. |
| [1] | Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417. |
| [2] | Yan LIU,Beizhen PAN,Jifei YANG,Xianyu ZHANG,Wenbo DING,Lingli SONG,Yundong ZHAO. Expression of quorum sensing related genes in multidrug-resistant Pseudomonas aeruginosa and its effects on biofilm formation and drug resistance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 921-928. |
| [3] | Shuo ZHANG,Yunxiu XIA,Weiwei CHEN,Hongliang DONG,Bingjie CUI,Cuilan LIU,Zhiqiang LIU,Fei WANG,Jing DU. Effect of over-expression of NR2F2 on biological behaviors of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 58-67. |
| [4] | Bingbing HU,Kangning LUO,Su PENG,Yuzhong ZHOU,Maoliang CHEN,Changhua LIU. Improvement effect of down-regulation of miR-208a on 5-FU resistance in colorectal cancer cells through targeting SFRP1 for mediating Wnt signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 947-955. |
| [5] | Xuejun JIN,Chuyuan LU. Inhibitory effect of leucovorin on growth and angiogenesis of subcutaneous transplanted tumors in mouse lung cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 612-619. |
| [6] | Zhibo XU,Xinmiao JIANG,Yuqi ZHEN,MA Quzhen BAI,Mengyao SUN,Xiuping MENG. Effect of chlorhexidine on drug resistance and pathogenicity of Enterococcus faecalis and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 676-681. |
| [7] | Ying ZHANG,Zhaohui WAN,Xianxun JIANG. Effect of over-expression of NDRG1 on resistance of castration-resistant prostate cancer resistant cell line C4-2/ENZA and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 708-717. |
| [8] | ERDEMUTU,Yanyan WANG,Yutong LI,Guilin CHEN,Junrui WANG. Comparison of drug resistance of MRSA clinical strains from respiratory tract and non-respiratory tract specimens and their molecular epidemiological characteristics [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 422-430. |
| [9] | Chunyan KANG,Xiuzhi ZHANG,Huicong ZHOU,Jie CHEN. Effect of downregulating proline-rich protein 11 expression on drug resistance of esophageal cancer drug resistant cell EC9706/DDP and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 113-119. |
| [10] | Bo HUANG,Jie DING,Hongrong GUO,Hongjuan WANG,Jianqun XU,Quan ZHENG. Effects of HIF-1α/ROS on apoptosis and invasion of lung cancer A549 cells under hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 682-690. |
| [11] | Jiaojiao XUE,Lei HAO,Yuxiu ZHANG,Heyang DAI,Lixia ZHANG,Shaowei GUO,Jingjing ZHANG,Yang LI,Qingxia LI. Effect of Huaier aqueous extract on breast cancer tamoxifen-resistant LCC2 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 714-721. |
| [12] | Yanan MA,Bing TAN,Lei XU,Jiandong ZHANG. Detection of drug resistance genes of Acinetobacter baumannii in sputum samples of ICU patients by real-time fluorescence quantitative PCR method and its evaluation [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1623-1628. |
| [13] | Shunjia SONG,Xinying WANG,Feifei JIANG,Huijian JIA,Yuan ZHAO,Zhiping YANG,Liyuan SUN,Yundong ZHAO. Resistance rates of Helicobacter pylori to clarithromycin, metronidazole, and levofloxacin and mutation characteristics of their related drug resistance genes [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 630-637. |
| [14] | Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743. |
| [15] | Lisong CHEN,Hui FANG,Hefei WANG,Chengyuan HE,Xiaodong GAI,Chun LI. Effects of Notch1 signaling pathway on invasion and cisplatin resistance of lung adenocarcinoma cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1171-1177. |
|